Kynurenine metabolism in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 112, Issue 2, 2005, Pages 93-96

  Hartai, Z ^a   Klivenyi, P ^a   Janaky, T ^a   Penke, B ^a   Dux, L ^a   Vecsei, Laszlo ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Excitotoxicity; Kynurenic acid; Kynurenine aminotransferase; Multiple sclerosis

Indexed keywords

EXCITATORY AMINO ACID RECEPTOR; KYNURENINE; KYNURENINE AMINOTRANSFERASE; KYNURENINE AMINOTRANSFERASE I; KYNURENINE AMINOTRANSFERASE II; QUINOLINIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID METABOLISM; ARTICLE; BRAIN FUNCTION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; METABOLITE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NEUROTOXICITY; PATHOGENESIS; PLASMA; RECEPTOR BLOCKING;

ADOLESCENT; ADULT; ERYTHROCYTES; FEMALE; HUMANS; KYNURENIC ACID; KYNURENINE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; TRANSAMINASES; UP-REGULATION;

EID: 22344443211     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00442.x     Document Type: Article

References (23)

1. OKUNO E, NAKAMURA M, SCHWARCZ R. Two kynurenine aminotransferases in human brain. Brain Res 1991;542:307-12.
2. HILMAS C, PEREIRA EF, ALKONDON M, RASSOULPOUR A, SCHWARCZ R, ALBUQUERQUE EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 2001;21:7463-73.
3. BARAN H, JELLINGER K, DEECKE L. Kynurenine metabolism in Alzheimer's disease. J Neural Transm 1999;106:165-81.
4. KLIVENYI P, TOLDI J, VECSEI L. Kynurenines in neurodegenerative disorders: therapeutic consideration. Adv Exp Med Biol 2004;541:169-83.
5. BARAN H, CAIRNS N, LUBEC B, LUBEC G. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Life Sci 1996;58:1891-9.
6. BARAN H, HAINFELLNER JA, KEPPLINGER B, MAZAL PR, SCHMID H, BUDKA H. Kynurenic acid metabolism in the brain of HIV-1 infected patients. J Neural Transm 2000;107:1127-38.
7. HEMMER B, KIESEIER B, CEPOK S, HARTUNG HP. New immunopathologic insights into multiple sclerosis. Curr Neurol Neurosci Rep 2003;3:246-55.
8. MARTINO G, FURLAN R, BRAMBILLA E et al. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J Neuroimmunol 2000;109:3-9.
9. FAZAKERLEY JK, WALKER R. Virus demyelination. J Neurovirol 2003;9:148-164.
10. RASMUSSEN HB, LUCOTTE G, CLAUSEN J. Endogenous retroviruses and multiple sclerosis. J Neurovirol 2000;6(Suppl. 2):S80-4.
11. DYMENT DA, EBERS GC, SADOVNICK AD. Genetics of multiple sclerosis. Lancet Neurol 2004;3:104-10.
12. PATNEAU DK, WRIGHT PW, WINTERS C, MAYER ML, GALLO V. Glial cells of the oligodendrocyte lineage express both kainate and AMPA preferring subtypes of glutamate receptor. Neuron 1994;12:357-71.
13. GURWITZ D, KLOOG Y. Peroxynitrite generation might explain elevated glutamate and aspartate levels in multiple sclerosis cerebrospinal fluid. Eur J Clin Invest 1998;28:760-1.
14. BAIG S, HALAWA I, QURESHI GA. High performance liquid chromatography as a tool in the definition of abnormalities in monoamine and tryptophan metabolites in cerebrospinal fluid from patients with neurological disorders. Biomed Chromatogr 1991;5:108-12.
15. SARCHIELLI P, GRECO L, FLORIDI A, FLORIDI A, GALLAI V. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 2003;60:1082-8.
16. KLIVENYI P, KEKESI K, JUHASZ G, VECSEI L. Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis. Acta Neurol Scand. 1997;95:96-8.
17. SMITH T, GROOM A, ZHU B, TURSKI L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000;6:62-6.
18. REJDAK K, BARTOSIK-PSUJEK H, DOBOSZ B et al. Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neurosci Lett 2002;331:63-5.
19. KARG E, KLIVENYI P, NEMETH I, PINTER S, VECSEI L. Non-enzymatic antioxidants of blood in multiple sclerosis. J Neurol 1999;246:533-9.
20. MASON M. The kynurenine transaminase of rat kidney. J Biol Chem 1954;211:839.
21. SWARTZ KJ, MATSON WR, MACGARVEY U, RYAN EA, BEAL MF. Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal Biochem 1990;185:363-76.
22. BERTAZZO A, BIASIOLO M, COSTA LVC, ALLEGRI G, RAGAZZI E, FASSINA G. Kynurenine aminotransferase in hypercholesterolemic rats. In: Filippini GA, ed. Advances in Tryptophan Research. New York: Plenum Press, 1996;12-15.
23. GUIDETTI P, OKUNO E, SCHWARCZ R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 1997;50:457-465.